Royal Bank Of Canada Anixa Biosciences Inc Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 1,000 shares of ANIX stock, worth $2,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,428
29.97%
Holding current value
$2,480
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.56MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.45 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$1.66 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.54 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.31 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.26 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $76M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...